| Dr Kelly Bolling-ringler, | |
|
51781 Huntington Rd, La Pine, OR 97739 | |
| (541) 666-7920 | |
| Not Available |
| Full Name | Dr Kelly Bolling-ringler |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 51781 Huntington Rd, La Pine, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639531171 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD188081 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Partners Home Health | Bend, OR | Home health agency |
| St Charles Medical Center - Bend | Bend, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Charles Health System Inc | 8729111513 | 206 |
News Archive
A new study being published in the journal Urology shows that Proantinox, a proprietary cranberry-based blend used successfully in hospitals and long-term care facilities as UTI-Stat, and now available directly to consumers as new Cystex Liquid Cranberry Complex with Proantinox, is safe and effective in significantly reducing the incidence of UTIs in women at risk for recurring infections.
Researchers are ramping up production of a promising drug that has proven effective in obliterating SARS-CoV in cellular cultures. The team hopes that the drug might also be effective in the fight against SARS's close genetic cousin, the novel coronavirus (COVID-19).
The presence of an immune-suppressing protein in non-cancerous immune cells may predict how patients with different types of cancer respond to treatment, a multi-center phase I study using an investigational immune therapy drug has found.
Combined whole exome tumor and blood sequencing in pediatric cancer patients revealed mutations that could help explain the cause of cancer or have the potential to impact clinical cancer care in 40 percent of patients in a study led by researchers from Baylor College of Medicine and Texas Children's Cancer Center.
› Verified 3 days ago
| Entity Name | St Charles Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023331303 PECOS PAC ID: 8729111513 Enrollment ID: O20100730000227 |
News Archive
A new study being published in the journal Urology shows that Proantinox, a proprietary cranberry-based blend used successfully in hospitals and long-term care facilities as UTI-Stat, and now available directly to consumers as new Cystex Liquid Cranberry Complex with Proantinox, is safe and effective in significantly reducing the incidence of UTIs in women at risk for recurring infections.
Researchers are ramping up production of a promising drug that has proven effective in obliterating SARS-CoV in cellular cultures. The team hopes that the drug might also be effective in the fight against SARS's close genetic cousin, the novel coronavirus (COVID-19).
The presence of an immune-suppressing protein in non-cancerous immune cells may predict how patients with different types of cancer respond to treatment, a multi-center phase I study using an investigational immune therapy drug has found.
Combined whole exome tumor and blood sequencing in pediatric cancer patients revealed mutations that could help explain the cause of cancer or have the potential to impact clinical cancer care in 40 percent of patients in a study led by researchers from Baylor College of Medicine and Texas Children's Cancer Center.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kelly Bolling-ringler, 2500 Ne Neff Rd, Bend, OR 97701-6015 Ph: () - | Dr Kelly Bolling-ringler, 51781 Huntington Rd, La Pine, OR 97739 Ph: (541) 666-7920 |
News Archive
A new study being published in the journal Urology shows that Proantinox, a proprietary cranberry-based blend used successfully in hospitals and long-term care facilities as UTI-Stat, and now available directly to consumers as new Cystex Liquid Cranberry Complex with Proantinox, is safe and effective in significantly reducing the incidence of UTIs in women at risk for recurring infections.
Researchers are ramping up production of a promising drug that has proven effective in obliterating SARS-CoV in cellular cultures. The team hopes that the drug might also be effective in the fight against SARS's close genetic cousin, the novel coronavirus (COVID-19).
The presence of an immune-suppressing protein in non-cancerous immune cells may predict how patients with different types of cancer respond to treatment, a multi-center phase I study using an investigational immune therapy drug has found.
Combined whole exome tumor and blood sequencing in pediatric cancer patients revealed mutations that could help explain the cause of cancer or have the potential to impact clinical cancer care in 40 percent of patients in a study led by researchers from Baylor College of Medicine and Texas Children's Cancer Center.
› Verified 3 days ago
Joe T Mccook, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 51600 Huntington Rd, La Pine, OR 97739 Phone: 541-536-3435 | |
Casey Scott Law, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 51781 Huntington Rd, La Pine, OR 97739 Phone: 541-666-7920 Fax: 541-666-7919 | |
Rio Lion, D.O Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 51600 Huntington Rd, La Pine, OR 97739 Phone: 541-536-3435 | |
Dr. Beth E Blumenstein, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 51600 Huntington Rd, La Pine, OR 97739 Phone: 541-536-3435 Fax: 541-536-8047 | |
Adaobi Okonkwo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 51600 Huntington Rd, La Pine, OR 97739 Phone: 541-536-3435 | |
Joan Blum Friderici, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 51600 Huntington Rd, La Pine, OR 97739 Phone: 541-536-3435 Fax: 541-536-8047 |